Day One Biopharmaceuticals I shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Day One Biopharmaceuticals I
Tip: Access up to 7 years of quarterly data
All positions including Day One Biopharmaceuticals I held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Day One Biopharmaceuticals I by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $820k | 116k | 7.05 |
| 2025-06-30 | $1.1M | 175k | 6.50 |
| 2025-03-31 | $890k | 112k | 7.93 |
| 2024-12-31 | $958k | 76k | 12.67 |
| 2024-09-30 | $908k | 65k | 13.93 |
| 2024-06-30 | $961k | 70k | 13.78 |
| 2024-03-31 | $626k | 38k | 16.52 |
| 2023-12-31 | $209k | 14k | 14.60 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas